Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Options and Sells Shares Under 10b5-1 Plan

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock between May 1 and May 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., executed stock options to acquire Class A Common Stock at a price of $0.40 per share between May 1 and May 3, 2024.
• Concurrently, Baird sold portions of these shares on the open market at prices ranging from $11.21 to $13.12 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2023.
• The total number of shares sold over the three days was 36,044.
• Following these transactions, Baird directly owns 538,932 shares of Class A Common Stock.
• Baird also holds options to purchase 704,908 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy. It doesn't necessarily indicate a positive or negative outlook on the company's performance.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the existence of a 10b5-1 plan mitigates this concern.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice among executives at publicly traded companies, including competitors in the telehealth and wellness space.
• Similar filings are regularly seen from executives at companies like Teladoc Health and GoodRx, reflecting routine stock option exercises and sales.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the effect of stock sales on the market price.

Key Dates